Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 5.1 Opinion of Goodwin Procter LLP
- 12.1 Calculation of Ratios of Earnings to Fixed Charges
- 21.1 Subsidiaries of the Company
- 23.1 Consent of Bdo Seidman, LLP
- 23.2 Consent of Bdo Seidman, LLP
- 23.3 Consent of Deloitte and Touche LLP
- 25.1 Form T-1 Statement of Eligibility
- 99.1 Form Letter of Transmittal
- 99.2 Form Notice of Guaranteed Delivery
- 99.3 Form Letter to Registered Holders and DTC Participants
- 99.4 Form Letter to Clients
Alere International Holding similar filings
- 26 Mar 10 Registration of securities issued in business combination transactions (amended)
- 12 Feb 10 Registration of securities issued in business combination transactions
- 14 Feb 05 Registration of securities issued in business combination transactions (amended)
- 1 Jul 04 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Inverness Medical Innovations, Inc.
Waltham, MA
We hereby consent to the incorporation by reference in the Prospectus constituting a part of this Registration Statement on Form S-4 of Inverness Medical Innovations, Inc. (the “Company”) of our report dated August 21, 2003 (except for the matter disclosed in Note 13, for which the date is August 27, 2003) relating to the consolidated financial statements of Applied Biotech, Inc. and subsidiary appearing in the Company’s current report on Form 8-K/A, filed on November 10, 2003.
/s/ BDO Seidman, LLP
Boston, Massachusetts
June 30, 2004